Australia’s bourse hit another record high today.

The ASX 200 rose 0.54%, closing at 7,629 points which is 14% higher than the start of 2021 and 6.9% higher than mid February 2020.

The ASX Emerging Companies Index meanwhile retreated 0.23%, closing at 2,312.

All sectors save resources sector finished in the green with health leading the pack with a gain of nearly 2% and even resources only just finished in the red.

The ASX’s rise was in line with Wall Street, which rose on positive economic data bolstering confidence about the US economy – specifically initial jobless claims falling for the third week in a row.

Exchanges in the Asia-Pacific region however mostly fell with Shanghai and China falling over 0.40% while Seoul fell by over 1.4%.



Scroll or swipe to reveal table. Click headings to sort.

Stocks highlighted in yellow rose after making announcements during intraday trade.

None of the top 25 ASX stocks rose off the back of announcements. But one notable winner was Australian Rare Earths (ASX:AR3), which gained another 16% today and is now up 292% since its IPO at the start of July.



Scroll or swipe to reveal table. Click headings to sort.

Stocks highlighted in yellow rose after making announcements during intraday trade.

Pot stock Cann Group (ASX:CAN) terminated its agreement with Emyria (ASX:EMD), which could have seen the pair register a schedule 3 over-the-counter cannabidiol medicine product with the TGA.



The NSX (ASX:NSX) announced Graeme Samuel’s departure just four months after he joined. The company made no further comment except thanking him for his contribution.

PointsBet (ASX:PBH) launched online sports betting in West Virginia. This follows regulatory approval from local regulators and marks the seventh state its premium sports betting product is operational in.

Supercomputing stock DUG Technology (ASX:DUG) was awarded a five year contract by Omani-based CC Energy Development to provide advanced seismic imaging services. The company says the first two will bring revenue of US$450,000.

Emyria (ASX:EMD) is partnering with North American drug manufacturer AltaSciences to develop a CBD product.

Beauty clinic operator Wellness & Beauty Solutions (ASX:WNB) looks like it might have another chance at life under the leadership of Direct Connect founder and BRC Capital chief Paul Docherty. The administrators have appointed a new board of directors including Docherty and said the new board “has a new vision and direction for Wellness and looks forward to working with shareholders to build Wellness into a successful and profitable company”.




Creso Pharma (ASX:CPH) – Health Canada license
Galan Lithium (ASX:GLN) – capital raising
Dimerix (ASX:DXB) – capital raising
Alexium (ASX:AJX) – sales update clarification


Nuheara (ASX:NUH) – clinical trial commencement
African Energy Resources (ASX:AFR) – capital raising
Alkane Resources (ASX:ALK) – exploration results
Firefinch (ASX:FFX) – joint venture update
Dropsuite (ASX:DSE) – capital raising